Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year
Intelligent Bio Solutions reported fiscal Q3 revenue of $1.06 million, up 46% year-over-year, driven by a 59% surge in recurring cartridge revenue which now makes up 66% of sales. Gross profit margin expanded to 50.5% in the quarter, up from 46.8% a year ago, as the company benefits from a new manufacturing partnership and higher-margin consumable sales.
Key figures
- Revenue
- 1060802
- Revenue Yoy
- 46%
- Cash balance
- 6862204
- Gross margin
- 50.5%
- Gross profit
- 535381
- Capital raised
- 14670000
- Cartridge revenue
- 703538
- Marketing spend yoy
- -42%
- Reverse split ratio
- 1-for-10
- Cartridge revenue yoy
- 59%
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.